[1]
L. A. R. Alfatli and T.-A. R. Tweij, “Aprocitentan mitigates ischemia reperfusion induced kidney injury in rats by attenuating inflammation and pyroptosis through suppressing NF-κB/NLRP3/caspase-1 signaling pathway”, Eur J Clin Exp Med, vol. 23, no. 4, pp. 936–946, Dec. 2025.